Particularly, miR-217 induces tumor suppression by targeting downstream genes such as astrocyte elevated gene-1 (AEG-1), mitogen-activated protein kinase (MAPK), and zinc finger E-box binding homeobox 1 (ZEB1). This evidence concerns the gene MTDH and neoplasm.